220 related articles for article (PubMed ID: 20151425)
1. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry.
Lee J; Hoang BH; Ziogas A; Zell JA
Cancer; 2010 Apr; 116(8):1964-73. PubMed ID: 20151425
[TBL] [Abstract][Full Text] [Related]
2. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
3. Effects of socioeconomic status and treatment disparities in colorectal cancer survival.
Le H; Ziogas A; Lipkin SM; Zell JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1950-62. PubMed ID: 18708384
[TBL] [Abstract][Full Text] [Related]
4. Extraskeletal Ewing's sarcoma.
Ahmad R; Mayol BR; Davis M; Rougraff BT
Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746
[TBL] [Abstract][Full Text] [Related]
5. [Descriptive epidemiology of Ewing's tumor--analysis of German patients from (EI)CESS 1980-1997].
Hense HW; Ahrens S; Paulussen M; Lehnert M; Jürgens H
Klin Padiatr; 1999; 211(4):271-5. PubMed ID: 10472561
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and Ewing sarcoma--relationship to pulmonary metastasis and survival.
Mikulić D; Ilić I; Cepulić M; Giljević JS; Orlić D; Zupancić B; Fattorini I; Seiwerth S
J Pediatr Surg; 2006 Mar; 41(3):524-9. PubMed ID: 16516628
[TBL] [Abstract][Full Text] [Related]
7. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
Shankar AG; Ashley S; Craft AW; Pinkerton CR
Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
[TBL] [Abstract][Full Text] [Related]
8. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
Lee JA; Kim DH; Lim JS; Koh JS; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
Jpn J Clin Oncol; 2010 Nov; 40(11):1060-7. PubMed ID: 20513751
[TBL] [Abstract][Full Text] [Related]
9. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.
Esiashvili N; Goodman M; Marcus RB
J Pediatr Hematol Oncol; 2008 Jun; 30(6):425-30. PubMed ID: 18525458
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
[TBL] [Abstract][Full Text] [Related]
11. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
[TBL] [Abstract][Full Text] [Related]
12. Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992.
Sandoval C; Meyer WH; Parham DM; Kun LE; Hustu HO; Luo X; Pratt CB
Med Pediatr Oncol; 1996 Mar; 26(3):180-5. PubMed ID: 8544800
[TBL] [Abstract][Full Text] [Related]
13. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p16 INK4a alteration for Ewing sarcoma: a meta-analysis.
Honoki K; Stojanovski E; McEvoy M; Fujii H; Tsujiuchi T; Kido A; Takakura Y; Attia J
Cancer; 2007 Sep; 110(6):1351-60. PubMed ID: 17661343
[TBL] [Abstract][Full Text] [Related]
15. A single institution experience of combined modality management of extra skeletal Ewings sarcoma.
Venkitaraman R; George MK; Ramanan SG; Sagar TG
World J Surg Oncol; 2007 Jan; 5():3. PubMed ID: 17217537
[TBL] [Abstract][Full Text] [Related]
16. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma.
De Angulo G; Hernandez M; Morales-Arias J; Herzog CE; Anderson P; Wolff J; Kleinerman ES
J Pediatr Hematol Oncol; 2007 Jan; 29(1):48-52. PubMed ID: 17230066
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma and the development of secondary malignancies.
Fuchs B; Valenzuela RG; Petersen IA; Arndt CA; Sim FH
Clin Orthop Relat Res; 2003 Oct; (415):82-9. PubMed ID: 14612633
[TBL] [Abstract][Full Text] [Related]
18. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.
Rodríguez-Galindo C; Liu T; Krasin MJ; Wu J; Billups CA; Daw NC; Spunt SL; Rao BN; Santana VM; Navid F
Cancer; 2007 Jul; 110(2):375-84. PubMed ID: 17569105
[TBL] [Abstract][Full Text] [Related]
19. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
Schovanec J; Mrácek J; Havlas V; Trc T
Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
[TBL] [Abstract][Full Text] [Related]
20. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.
Billingsley KG; Lewis JJ; Leung DH; Casper ES; Woodruff JM; Brennan MF
Cancer; 1999 Jan; 85(2):389-95. PubMed ID: 10023707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
